Shenzhen Zhenxing Medical Technology Co., Ltd
1 clinical trials · Sponsor
◉ Watch Shenzhen Zhenxing Medical Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas (NCT07635173) | Shenzhen Zhenxing Medical Technology Co., Ltd | 2022-09-19 |
Track Shenzhen Zhenxing Medical Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.